We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$26.2B
AUM Growth
+$914M
(+3.6%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
3.87%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
1,591
New
69
Increased
817
Reduced
431
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$107M |
| 2 |
EXL Service
EXLS
|
+$72M |
| 3 |
Apple
AAPL
|
+$64.3M |
| 4 |
Synopsys
SNPS
|
+$56.8M |
| 5 |
ServiceNow
NOW
|
+$54.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halozyme
HALO
|
+$74.5M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$53.5M |
| 3 |
Edwards Lifesciences
EW
|
+$45M |
| 4 |
Abbott
ABT
|
+$40.3M |
| 5 |
Rockwell Automation
ROK
|
+$39.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.4% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 12.04% |
| 4 | Communication Services | 9.47% |
| 5 | Industrials | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
NCR Atleos
NATL
$3.47B
| $770K | ﹤0.01% |
+22,700
| New | +$688K |
|
1102
Progress Software
PRGS
$1.83B
| $770K | ﹤0.01% |
11,816
+2,600
| +28% | +$174K |
|
1103
Matsons
MATX
$6.39B
| $769K | ﹤0.01% |
5,700
| – | – |
|
1104
Sweetgreen
SG
$721M
| $769K | ﹤0.01% |
24,000
+7,000
| +41% | +$261K |
|
1105
CONMED
CNMD
$1.49B
| $768K | ﹤0.01% |
11,223
+1,200
| +12% | +$83.6K |
|
1106
Cathay General Bancorp
CATY
$4.31B
| $766K | ﹤0.01% |
16,088
+1,600
| +11% | +$77.1K |
|
1107
Coty
COTY
$2.42B
| $765K | ﹤0.01% |
109,900
-4,000
| -4% | -$30.7K |
|
|
MPT
1108
Medical Properties Trust
MPT
$2.51B
| $765K | ﹤0.01% |
193,552
-46,200
| -19% | -$207K |
|
|
CVSA
1109
Covista Inc
CVSA
$4.49B
| $763K | ﹤0.01% |
8,395
+200
| +2% | +$16.7K |
|
1110
JFrog
FROG
$11.5B
| $759K | ﹤0.01% |
25,800
+2,100
| +9% | +$63.7K |
|
1111
InvenTrust Properties
IVT
$2.62B
| $759K | ﹤0.01% |
25,200
+3,000
| +14% | +$90.3K |
|
1112
Riot Platforms
RIOT
$7.21B
| $757K | ﹤0.01% |
74,100
+7,300
| +11% | +$79.5K |
|
|
OPLN
1113
Openlane
OPLN
$4.33B
| $756K | ﹤0.01% |
38,125
+3,600
| +10% | +$66.4K |
|
1114
Amkor Technology
AMKR
$14.3B
| $755K | ﹤0.01% |
29,376
+6,200
| +27% | +$171K |
|
1115
AST SpaceMobile
ASTS
$21.4B
| $755K | ﹤0.01% |
+35,800
| New | +$874K |
|
1116
First Bancorp
FBP
$4.49B
| $755K | ﹤0.01% |
40,631
-700
| -2% | -$14.1K |
|
1117
Visteon
VC
$2.86B
| $750K | ﹤0.01% |
8,451
| – | – |
|
1118
QuidelOrtho
QDEL
$1.03B
| $749K | ﹤0.01% |
16,819
+2,000
| +13% | +$81.8K |
|
1119
Empire State Realty Trust
ESRT
$836M
| $748K | ﹤0.01% |
72,518
+10,400
| +17% | +$113K |
|
1120
Acushnet Holdings
GOLF
$5.25B
| $746K | ﹤0.01% |
10,500
+1,400
| +15% | +$95.1K |
|
|
TGNA
1121
DELISTED
TEGNA Inc
TGNA
| $746K | ﹤0.01% |
40,808
+3,300
| +9% | +$57.7K |
|
1122
Virtu Financial
VIRT
$5.05B
| $746K | ﹤0.01% |
20,900
-1,000
| -5% | -$34.4K |
|
1123
Fulton Financial
FULT
$4.69B
| $743K | ﹤0.01% |
38,513
+6,500
| +20% | +$127K |
|
1124
Kulicke & Soffa
KLIC
$5.01B
| $741K | ﹤0.01% |
15,874
+2,600
| +20% | +$122K |
|
|
CPRX
1125
DELISTED
Catalyst Pharmaceutical
CPRX
| $740K | ﹤0.01% |
35,477
+1,000
| +3% | +$21.5K |
|
Similar funds
GAM
Handelsbanken Fonder's Q4 2024 Portfolio in Review
As of Q4 2024, Handelsbanken Fonder held 1,591 positions worth $26.2B, up 3.6% from $25.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder deployed $1.01B of net new capital in Q4 2024, opening 69 new positions and adding to 817 existing holdings. Its largest new stake was GE Vernova: 105,537 shares worth $34.7M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Halozyme, an estimated $74.5M trimmed.
- Handelsbanken Fonder's largest Q4 2024 buy was GE Vernova: 105,537 shares worth $34.7M.
- Handelsbanken Fonder added most to Microsoft in Q4 2024, an estimated $107M increase.
- Handelsbanken Fonder's biggest Q4 2024 reduction was Halozyme, cutting an estimated $74.5M.
- Handelsbanken Fonder fully exited BeOne Medicines Ltd in Q4 2024, selling an estimated $5.92M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $26.2B portfolio in Q4 2024.
- Handelsbanken Fonder opened 69 new positions and closed 49 in Q4 2024.
- Handelsbanken Fonder's portfolio value rose 3.6% quarter-over-quarter to $26.2B.
Based on Handelsbanken Fonder's 13F filing for Q4 2024, filed 3 Feb 2025.